FDA Approves Brain-Computer Interface By Precision Neuroscience

The U.S. Food and Drug Administration (FDA) approved a brain-computer interface, called the Layer 7 Cortical Interface, developed by Precision Neuroscience Corporation (Precision). The device is a high-resolution cortical electrode array that records, monitors, and stimulates electrical activity on the surface of the brain. It is a core component of Precision’s fully implantable, wireless brain-computer interface system, which is currently in development. The FDA granted 510(k) marketing clearance, which means that the Layer 7 Cortical Interface can be used commercially for implant durations of up to 30 days. The technology can be used for . . .